H3N2v Monovalent Inactivated Influenza Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for H3N2v Monovalent Inactivated Influenza Vaccine, covering 2014-02-28 to 2017-07-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations [Phase 2]